CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Biosidus amplía su capacidad de fabricación de productos biológicos

agalsidasa betaPositive
AI Analysis

Summary

Biosidus, an Argentine biotechnology company, announces expansion of its manufacturing capacity for biological products and strengthens its global supply of agalsidase beta.

Importance:3/10
Sentiment:
0.50
manufacturing capacity expansionbiopharmaceuticalsupply chainbiosimilar
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 27, 2026 2:30 AM

Read Original